AKT1 and cancer: BMS-754807 exerts a strong antineoplastic effect on several cancer model cells, apparently in a way mostly independent of IGF-1R inhibition and is able to inhibit the ERK1/2 and PI3K/AKT/mTOR signaling pathways, which are crucial for tumor cells to survive.